CBG vs CBD
Everyone seems to be asking, what is CBG? What are the differences between CBG and CBD? The simple answer is CBD assists with the production and regulation of the body’s endocannabinoids. While CBG works on the receptors. Unlike CBD, which has a relatively low affinity for cannabinoid receptors and works mostly via indirect interactions with the endocannabinoid system, CBG is thought to evoke its therapeutic effects through direct interaction. Another way to differentiate the two – CGB typically energizes, whilst CBD has a more calming effect. The two balance each other out when taken together.
Another major differentiator with CBG is that it is the precursor from which every other cannabinoid is synthesized, which is why it’s often referred to as the “mother” or “stem cell” of cannabinoids. This makes CBG unique to every other cannabinoid and it also brings a great therapeutic promise, making it the subject of great interest for researchers and consumers alike.
Table of Contents
What is Cannabigerol (CBG)?
Cannabigerol is one of more than 120 identified cannabinoid compounds found in the plant genus Cannabis. Cannabigerol is the decarboxylated form of Cannabigerol acid, the parent molecule from which other cannabinoids are synthesized. Cannabigerol is a minor constituent of cannabis.
Cannabigerol, aka CBG, was first discovered in Israel in 1964 by researchers Yehiel Gaoni and Raphael Mechoulam, along with dozens of other cannabinoids. Shortly after this discovery, Gaoni and Mechoulam found a new neurobiological system, now known as the endocannabinoid system. While their later work mostly pertained to the effects of THC, their discovery has laid the groundwork for further research into this incredibly intricate plant and the corresponding functions within this system.
How Is CBG Made?
CBG is derived from young cannabis plants because they contain higher amounts of CBG than fully developed plants. Some strains of cannabis like White CBG, Super Glue CBG, and Jack Frost CBG also have higher CBG content than other strains. These strains are specifically cultivated to produce higher quantities of CBG.
Both CBD and THC start as CBGA, an acidic form of CBG. This is why younger cannabis plants contain higher concentrations of CBG. In fully developed plants with high concentrations of THC and CBD, you’ll find very low concentrations of CBG. This happens because most of the CBG has already been converted to CBD and THC as the plant developed.
Due to the difficulty of getting CBG, cannabis growers have been experimenting with cross-breeding and genetic manipulation to help cannabis plants produce more CBG.
How does CBG work?
CBG is processed by the body’s endocannabinoid system. The endocannabinoid system is made up of molecules and receptors in our bodies that are responsible for keeping our bodies in an optimal state regardless of what’s going on in our external environment.
CBG & the Endocannabinoid System
So, after all the genetic engineering, what exactly does CBG do? On the surface, CBG has many similar effects as CBD, having been observed to combat pain and mitigate the intoxicating effects of THC without any psychoactive qualities (as in, it won’t make you feel a “high”). However, unlike CBD, CBG interacts with both CB1 and CB2 receptors. It has also demonstrated an ability to increase anandamide, or “the bliss molecule,” which plays a critical role in the regulation of many functions within the body including memory, pain, appetite, mood, and sleep.
CBG side effects
The limited research on CBG also means that there is no reliable information about potential side effects. From what we know, and from previous research on CBD, Cannabigerol seems to be very easily tolerated, has very low toxicity, and there have not been any significant side effects observed as long as it is consumed in normal doses.As always, it is advisable to consult with your physician before adding CBG to your regime, especially if you are taking prescribed medication.
The production difficulties of CBG make it very scarce. It’s much harder to produce than other cannabinoids like THC and CBD. Since CBG shares many similarities with CBD, manufacturers would rather produce CBD. When CBG is produced, products derived from it are very expensive. However, CBG has a host of promising potential benefits and more research is being done into easing the production and availability of the cannabinoid.
Will CBG get me high?
No, CBG won’t get you high. Like CBD, Cannabigerol is mildly psychoactive but not psychotropic. CBG and CBD affect the brain very differently from THC, and they do not come with intoxicating effects. In high concentrations, CBG may induce effects of relaxation and euphoria, but the majority of the effects that this cannabinoid has on your system are not psychological.
The same rules apply to CBG. CBG isolate and broad-spectrum oil that contains CBG are generally safe to consume before a drug test. If your CBG oil contains THC, then there is a risk of a failed drug test—depending on the sensitivity of the assay and the THC content of your product.
Where to buy CBG?
If you’re looking to buy CBG Simple Leaf sells Premium CBG manufactured from organic hemp grown in the USA.
Simple Leaf CBD uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. We fact-check and keep our content accurate, reliable, and trustworthy.
1. What is CBG? The minor cannabinoid with major potential explained. Journal of Cannabinoid Medicine.
2. Borrelli F, Fasolino I, Romano B, et al. Beneficial effect of the non-psychotropic plant cannabinoid Cannabigerol on experimental inflammatory bowel disease. Biochemical Pharmacology. 2013;85(9):1306-1316.
3. Colasanti BK. A comparison of the ocular and central effects of tetrahydrocannabinol and cannabigerol. Journal of Ocular Pharmacology and Therapeutics. 1990;6(4):259-269.
4. Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O. Neuroprotective properties of cannabigerol in huntington’s disease: studies in r6/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics. 2015;12(1):185-199.
5. Farha MA, El-Halfawy OM, Gale RT, et al. Uncovering the hidden antibiotic potential of cannabis. ACS Infect Dis. 2020;6(3):338-346.
6. Orrego-González E, Londoño-Tobón L, Ardila-González J, Polania-Tovar D, Valencia-Cárdenas A, Velez-Van Meerbeke
A. Cannabinoid effects on experimental colorectal cancer models reduce aberrant crypt foci (Acf) and tumor volume: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2020;2020:1-13.